Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population

[1]  Jessica H Hayward,et al.  Trends in Breast Cancer Screening in a Safety-Net Hospital During the COVID-19 Pandemic , 2021, JAMA network open.

[2]  S. Lipsitz,et al.  Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic , 2021, Cancer Cell.

[3]  J. Haas,et al.  The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis , 2021, Preventive Medicine.

[4]  P. Monsivais,et al.  Socioeconomic and Racial Inequities in Breast Cancer Screening During the COVID-19 Pandemic in Washington State , 2021, JAMA network open.

[5]  K. Haynes,et al.  Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. , 2021, JAMA oncology.

[6]  D. Miglioretti,et al.  Changes in Mammography Utilization by Women’s Characteristics during the First 5 Months of the COVID-19 Pandemic , 2021, Journal of the National Cancer Institute.

[7]  D. Hershman,et al.  Care Delivery Impact of the COVID-19 Pandemic on Breast Cancer Care , 2021, JCO oncology practice.

[8]  I. Bleiweiss,et al.  Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic , 2021, JCO oncology practice.

[9]  L. Pusztai,et al.  Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic , 2021, Breast Cancer Research and Treatment.

[10]  L. Henderson,et al.  Population‐level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures , 2021, Cancer.

[11]  M. Zervos,et al.  Impact of Race and Socioeconomic Status on Outcomes in Patients Hospitalized with COVID-19 , 2021, Journal of General Internal Medicine.

[12]  S. Lipsitz,et al.  Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. , 2021, JAMA oncology.

[13]  W. King,et al.  Mortality due to cancer treatment delay: systematic review and meta-analysis , 2020, BMJ.

[14]  D. Patt,et al.  Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors , 2020, JCO clinical cancer informatics.

[15]  Brendan R. Jackson,et al.  Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 — United States, May–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[16]  P. Karaca-Mandic,et al.  Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States. , 2020, JAMA internal medicine.

[17]  E. Papautsky,et al.  Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic , 2020, Breast Cancer Research and Treatment.

[18]  K. Hughes,et al.  Breast imaging, breast surgery, and cancer genetics in the age of COVID‐19 , 2020, Cancer.

[19]  J. London,et al.  Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters. , 2020, JCO clinical cancer informatics.

[20]  Jean L Wright,et al.  Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach. , 2020, JCO oncology practice.

[21]  E. Price-Haywood,et al.  Hospitalization and Mortality among Black Patients and White Patients with Covid-19 , 2020, The New England journal of medicine.

[22]  W. Gradishar,et al.  Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium , 2020, Breast Cancer Research and Treatment.

[23]  G. Pravettoni,et al.  Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic , 2020, The Breast.

[24]  A. Khorana,et al.  Time to initial cancer treatment in the United States and association with survival over time: An observational study , 2019, PloS one.